Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics/pharmacodynamics of GW003 in breast cancer patients, with chemotherapy-induced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• GW003

Snippet

Sponsor: Jiangsu T-Mab Biopharma Co.,Ltd | Conditions: Chemotherapy-induced Neutropenia | Phase 1 | Status: UNKNOWN